why so little interest?

I've done a bit of research into this company and from what I can gather they seem to have a bit going for them. I have a couple of questions for people who have been following this for a while, and as I'm a little new to the world of biotech companies they will be newby sorts of questions (for that I'm sorry!).

What sort of potential time lines exist for some results which would spur interest from a broader scale of investors? Is it only when they get closer to some sort of commercialisation that investors will perk up, or has it just been flying under the radar?

If you could compare MTY to a company like PRR, would you say that MTY are many years behind? For instance, how long might it take for MTY to have a product which is being tested by the FDA?

Also, what are your general opinions of the company in terms of management and potential?

Thankyou muchly in advance!